{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T02:57:47Z","timestamp":1773111467847,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,4,23]],"date-time":"2015-04-23T00:00:00Z","timestamp":1429747200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12931-015-0210-x","type":"journal-article","created":{"date-parts":[[2015,4,22]],"date-time":"2015-04-22T00:00:33Z","timestamp":1429660833000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Comparative effectiveness of budesonide\/formoterol combination and fluticasone\/salmeterol combination among chronic obstructive pulmonary disease patients new to controller treatment: a US administrative claims database study"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5417-3925","authenticated-orcid":false,"given":"David M","family":"Kern","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Setareh A","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozgur","family":"Tunceli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingcao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally","family":"Hollis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlie","family":"Strange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Trudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,4,23]]},"reference":[{"key":"210_CR1","unstructured":"American Lung Association. COPD fact sheet. 2011. Available from: http:\/\/www.lung.org\/lung-disease\/copd\/resources\/facts-figures\/COPD-Fact-Sheet.html . Last accessed June 6, 2013."},{"key":"210_CR2","unstructured":"What is COPD? National Heart Lung and Blood Institute; U.S.Department of Health & Human Services, 2013. Available from: http:\/\/www.nhlbi.nih.gov\/health\/health-topics\/topics\/copd . Last accessed June 20, 2013."},{"issue":"10","key":"210_CR3","first-page":"1184","volume":"47","author":"DM Mannino","year":"2002","unstructured":"Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance\u2013United States, 1971\u20132000. Respir Care. 2002;47(10):1184\u201399.","journal-title":"Respir Care"},{"issue":"5 Suppl","key":"210_CR4","doi-asserted-by":"publisher","first-page":"121S","DOI":"10.1378\/chest.121.5_suppl.121S","volume":"121","author":"DM Mannino","year":"2002","unstructured":"Mannino DM. COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest. 2002;121(5 Suppl):121S\u20136.","journal-title":"Chest"},{"key":"210_CR5","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of COPD, 2014. Available from: http:\/\/www.goldcopd.org . Last accessed December 17, 2014."},{"key":"210_CR6","volume-title":"SYMABICORT Prescribing Information","author":"LP AstraZeneca","year":"2010","unstructured":"AstraZeneca LP. SYMABICORT Prescribing Information. 2010. Available from: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2010\/021929s021lbl.pdf . Last accessed June 20, 2013."},{"key":"210_CR7","unstructured":"GlaxoSmithKline. Advair DISKUS Package Insert, 2014. Available from: https:\/\/www.gsksource.com\/gskprm\/htdocs\/documents\/ADVAIR-DISKUS-PI-MG.PDF Last accessed October 22, 2014."},{"key":"210_CR8","first-page":"CD010844","volume":"3","author":"KM Kew","year":"2014","unstructured":"Kew KM, Dias S, Cates CJ. Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis. Cochrane Database Syst Rev. 2014;3:CD010844.","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"210_CR9","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s40265-014-0214-8","volume":"74","author":"DW Mapel","year":"2014","unstructured":"Mapel DW, Roberts MH. Management of asthma and chronic obstructive pulmonary disease with combination inhaled corticosteroids and long-acting beta-agonists: a review of comparative effectiveness research. Drugs. 2014;74(7):737\u201355.","journal-title":"Drugs"},{"issue":"4","key":"210_CR10","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1164\/rccm.201204-0596PP","volume":"187","author":"J Vestbo","year":"2013","unstructured":"Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347\u201365.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"210_CR11","doi-asserted-by":"publisher","first-page":"769","DOI":"10.3111\/13696998.2011.622817","volume":"14","author":"M Roberts","year":"2011","unstructured":"Roberts M, Mapel D, Petersen H, Blanchette C, Ramachandran S. Comparative effectiveness of budesonide\/formoterol and fluticasone\/salmeterol for COPD management. J Med Econ. 2011;14(6):769\u201376.","journal-title":"J Med Econ"},{"issue":"7","key":"210_CR12","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.clinthera.2010.06.022","volume":"32","author":"L Blais","year":"2010","unstructured":"Blais L, Forget A, Ramachandran S. Relative effectiveness of budesonide\/formoterol and fluticasone propionate\/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence. Clin Ther. 2010;32(7):1320\u20138.","journal-title":"Clin Ther"},{"issue":"6","key":"210_CR13","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/joim.12067","volume":"273","author":"K Larsson","year":"2013","unstructured":"Larsson K, Janson C, Lisspers K, et al. Combination of budesonide\/formoterol more effective than fluticasone\/salmeterol in preventing exacerbations in chronic obstructive pulmonary disease: the PATHOS study. J Intern Med. 2013;273(6):584\u201394.","journal-title":"J Intern Med"},{"key":"210_CR14","doi-asserted-by":"publisher","first-page":"f3306","DOI":"10.1136\/bmj.f3306","volume":"346","author":"C Janson","year":"2013","unstructured":"Janson C, Larsson K, Lisspers KH, et al. Pneumonia and pneumonia related mortality in patients with COPD treated with fixed combinations of inhaled corticosteroid and long acting beta2 agonist: observational matched cohort study (PATHOS). BMJ. 2013;346:f3306.","journal-title":"BMJ"},{"key":"210_CR15","first-page":"CD010115","volume":"3","author":"KM Kew","year":"2014","unstructured":"Kew KM, Seniukovich A. Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2014;3:CD010115.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"210_CR16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.4104\/pcrj.2009.00072","volume":"19","author":"D Mapel","year":"2010","unstructured":"Mapel D, Schum M, Yood M, Brown J, Miller D, Davis K. Pneumonia among COPD patients using inhaled corticosteroids and long-acting bronchodilators. Prim Care Respir J. 2010;19(2):109\u201317.","journal-title":"Prim Care Respir J"},{"key":"210_CR17","volume-title":"Proportion of Days Covered (PDC) as a Preferred Method of Measuring Medication Adherence","author":"DP Nau","year":"2014","unstructured":"Nau DP. Proportion of Days Covered (PDC) as a Preferred Method of Measuring Medication Adherence. 2014. Available from: http:\/\/www.pqaalliance.org\/ . Last accessed October 20, 2014."},{"issue":"12","key":"210_CR18","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1002\/sim.3150","volume":"27","author":"PC Austin","year":"2008","unstructured":"Austin PC. A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003. Stat Med. 2008;27(12):2037\u201349.","journal-title":"Stat Med"},{"issue":"9","key":"210_CR19","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1093\/aje\/kwq224","volume":"172","author":"PC Austin","year":"2010","unstructured":"Austin PC. Statistical criteria for selecting the optimal number of untreated subjects matched to each treated subject when using many-to-one matching on the propensity score. Am J Epidemiol. 2010;172(9):1092\u20137.","journal-title":"Am J Epidemiol"},{"key":"210_CR20","unstructured":"Parsons L. Reducing bias in a propensity score matched-pair sample using greedy matching techniques; In SAS SUGI 26, 2001, Paper 214\u2013226. Available from: http:\/\/www2.sas.com\/proceedings\/sugi26\/p214-26.pdf (SUGI 26), 214\u2013226."},{"key":"210_CR21","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/sim.3782","volume":"29","author":"B Lee","year":"2010","unstructured":"Lee B, Lessler J, Stuart E. Improving propensity score weighting using machine learning. Stat Med. 2010;29:337\u201346.","journal-title":"Stat Med"},{"issue":"3","key":"210_CR22","first-page":"18","volume":"2","author":"A Liaw","year":"2002","unstructured":"Liaw A, Wiener M. Classification and regression by random forest. R News. 2002;2(3):18\u201322.","journal-title":"R News"},{"key":"210_CR23","doi-asserted-by":"crossref","unstructured":"Sekhon JS. Multivariate and propensity score matching software with automated balance optimization: the matching package for R. J Stat Softw 2014, 42(7)","DOI":"10.18637\/jss.v042.i07"},{"issue":"11","key":"210_CR24","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1136\/thoraxjnl-2012-202872","volume":"68","author":"S Suissa","year":"2013","unstructured":"Suissa S, Patenaude V, Lapi F, Ernst P. Inhaled corticosteroids in COPD and the risk of serious pneumonia. Thorax. 2013;68(11):1029\u201336.","journal-title":"Thorax"},{"issue":"7","key":"210_CR25","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1111\/j.1742-1241.2011.02685.x","volume":"65","author":"DM Halpin","year":"2011","unstructured":"Halpin DM, Gray J, Edwards SJ, Morais J, Singh D. Budesonide\/formoterol vs salmeterol\/fluticasone in COPD: a systematic review and adjusted indirect comparison of pneumonia in randomised controlled trials. Int J Clin Pract. 2011;65(7):764\u201374.","journal-title":"Int J Clin Pract"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12931-015-0210-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-015-0210-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-015-0210-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-015-0210-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T18:10:10Z","timestamp":1651774210000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-015-0210-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,23]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["210"],"URL":"https:\/\/doi.org\/10.1186\/s12931-015-0210-x","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,23]]},"assertion":[{"value":"11 February 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"52"}}